Abstract
Diabetes mellitus is the most common endocrine disorder affecting surgical patients; although it occurs in 10% of the general population it is seen in up to 25% of the surgical population. Historically, patients with diabetes undergoing surgery were deemed to be very high risk and were often denied the benefits of day surgery. The application of the integrated care pathway coupled with perioperative manipulation of patients’ drugs has transformed surgical care for people with diabetes. Despite these advances, harm from dysglycaemia is not infrequent. The challenge facing clinicians and patients is to further mitigate the harm from hypo- and hyperglycaemia.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
